ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 132 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.31 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,729,753 | -48.2% | 922,214 | 0.0% | 0.00% | -100.0% |
| Q4 2023 | $5,265,842 | -48.3% | 922,214 | -41.5% | 0.00% | -50.0% |
| Q2 2023 | $10,178,770 | -14.3% | 1,575,661 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $11,880,484 | +81.4% | 1,575,661 | +143.6% | 0.00% | +50.0% |
| Q4 2022 | $6,551,061 | +26.8% | 646,699 | +23.8% | 0.00% | +100.0% |
| Q3 2022 | $5,166,635 | +70.0% | 522,410 | +83.1% | 0.00% | 0.0% |
| Q2 2022 | $3,039,180 | +9.2% | 285,369 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,782,348 | -31.8% | 285,369 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $4,081,000 | +69.4% | 285,369 | +137.4% | 0.00% | 0.0% |
| Q3 2021 | $2,409,000 | +119.0% | 120,194 | +140.4% | 0.00% | – |
| Q2 2021 | $1,100,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $28,452,416 | 91.13% |
| Founders Fund Growth Management, LLC | 407,017 | $3,068,908 | 14.23% |
| Gruss & Co., LLC | 167,500 | $1,262,950 | 7.99% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $30,952,416 | 3.25% |
| Belmont Capital, LLC | 510,000 | $3,845,400 | 3.18% |
| Prosight Management, LP | 753,528 | $5,681,601 | 2.69% |
| Intellectus Partners, LLC | 872,483 | $6,578,520 | 2.08% |
| Casdin Capital, LLC | 2,520,000 | $19,000,800 | 1.56% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $13,022,958 | 1.50% |
| Orbimed Advisors | 4,180,768 | $31,522,991 | 0.62% |